MediaTek: Announcement by important subsidiary Xiangfa Investment Co., Ltd. to convene a board meeting (acting as shareholders' meeting)
MediaTek's important subsidiary, Xiangfa Investment Co., Ltd., announced the convocation of a board meeting (acting as a shareholders' meeting) on May 8, 2026. The meeting's agenda includes the approval of the 2025 operating report, financial statements, and earnings distribution plan, as well as deliberation on the appointment and audit fees of the independent auditor for 2026.
📋 Article Processing Timeline
- 📰 Published: May 8, 2026 at 09:00
- 🔍 Collected: May 9, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 9, 2026 at 08:31 (31 min after Collected)
1. Date of board resolution: 115/05/08
2. Date of shareholders' meeting convocation: 115/05/08
3. Location of shareholders' meeting convocation: Not applicable
4. Agenda Item 1, Reporting matters: None
5. Agenda Item 2, Approval matters:
(1) 2025 operating report.
(2) 2025 financial statements.
(3) 2025 earnings distribution plan.
6. Agenda Item 3, Discussion matters:
Appointment of independent auditor and audit fees for the 2026 financial and tax audit.
7. Agenda Item 4, Election matters: None
8. Agenda Item 5, Other proposals: None
9. Agenda Item 6, Extraordinary motions: None
10. Start date of share transfer suspension: NA
11. End date of share transfer suspension: NA
12. Other matters to be specified: None
2. Date of shareholders' meeting convocation: 115/05/08
3. Location of shareholders' meeting convocation: Not applicable
4. Agenda Item 1, Reporting matters: None
5. Agenda Item 2, Approval matters:
(1) 2025 operating report.
(2) 2025 financial statements.
(3) 2025 earnings distribution plan.
6. Agenda Item 3, Discussion matters:
Appointment of independent auditor and audit fees for the 2026 financial and tax audit.
7. Agenda Item 4, Election matters: None
8. Agenda Item 5, Other proposals: None
9. Agenda Item 6, Extraordinary motions: None
10. Start date of share transfer suspension: NA
11. End date of share transfer suspension: NA
12. Other matters to be specified: None